Zealand bought a US firm just before the world shut down: "That was quite lucky"

If Zealand Pharma had not purchased bankrupt US company Valeritas, the coronavirus would have made it impossible for the company to build up a US sales organization, says CEO Emmanuel Dulac.

Emmanuel Dulac, CEO of Zealand Pharma. Photo: Zealand Pharma/ PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles